Emma represents clients in intellectual property disputes. Her experience includes patent litigation in district courts across the country, federal jury trials, and post-grant proceedings at the United States Patent and Trademark Office (USPTO). Emma represents companies in a variety of patent matters, including those in the biotechnology, pharmaceutical and medical device industries. Emma also has a pro bono practice and has represented several clients seeking asylum in immigration proceedings.
Represented major pharmaceutical company in Hatch-Waxman patent infringement actions against 16 generic drugmaker defendant groups, relating to the defendant groups’ submissions of abbreviated new drug applications (ANDA) to the FDA seeking approval of generic versions of a first-in-class agent for the reversal of certain types of neuromuscular blockade in adults undergoing surgery.
Represented Fortune 500 company defending against two federal patent infringement actions and three actions in the Patent Trial and Appeal Board (PTAB) relating to allegations of infringement of consumer products.